MMP13-IN-7
MMP13-IN-7 is an orally active MMP-13 inhibitor with a Ki value of 1.5 nM. MMP13-IN-7 targets the zinc-dependent protease MMP-13 that cleaves type II collagen. MMP13-IN-7 reduces elevated type II collagen neoepitope levels and the severity of osteoarthritis-like joint lesions in a canine meniscectomy model. MMP13-IN-7 can be used for research on osteoarthritis.
For research use only. We do not sell to patients.
- CAS No.: 1112169-64-8
- Formula: C21H24FN7O5
- Molecular Weight:473.46
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
IC50 & Target
[1]|
MMP13 |
In Vitro
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Parmacokinetics
Chemical Information
-
CAS No. 1112169-64-8
-
Molecular Weight 473.46
-
Formula C21H24FN7O5
-
SMILES
O=C(C1=NC(C)=NC(C2=NN(C[C@@H]3OC[C@@H](CO)OC3)N=N2)=C1)NCC4=CC=C(F)C(OC)=C4
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
[1]. Ruminski PG, et al. Discovery of N-(4-Fluoro-3-methoxybenzyl)-6-(2-(((2S,5R)-5-(hydroxymethyl)-1,4-dioxan-2-yl)methyl)-2H-tetrazol-5-yl)-2-methylpyrimidine-4-carboxamide. A Highly Selective and Orally Bioavailable Matrix Metalloproteinase-13 Inhibitor for the Potential Treatment of Osteoarthritis. J Med Chem. 2016 Jan 14;59(1):313-27. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)